LU85725A1 - Nouvelles 8alpha-acylaminoergolines,leur preparation et leur utilisation comme medicaments - Google Patents

Nouvelles 8alpha-acylaminoergolines,leur preparation et leur utilisation comme medicaments Download PDF

Info

Publication number
LU85725A1
LU85725A1 LU85725A LU85725A LU85725A1 LU 85725 A1 LU85725 A1 LU 85725A1 LU 85725 A LU85725 A LU 85725A LU 85725 A LU85725 A LU 85725A LU 85725 A1 LU85725 A1 LU 85725A1
Authority
LU
Luxembourg
Prior art keywords
formula
group
alkyl
signifies
phenyl group
Prior art date
Application number
LU85725A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU85725A1 publication Critical patent/LU85725A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU85725A 1984-01-12 1985-01-10 Nouvelles 8alpha-acylaminoergolines,leur preparation et leur utilisation comme medicaments LU85725A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3400853 1984-01-12
DE3400853 1984-01-12

Publications (1)

Publication Number Publication Date
LU85725A1 true LU85725A1 (fr) 1985-10-22

Family

ID=6224786

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85725A LU85725A1 (fr) 1984-01-12 1985-01-10 Nouvelles 8alpha-acylaminoergolines,leur preparation et leur utilisation comme medicaments

Country Status (28)

Country Link
US (2) US4950672A (sv)
JP (1) JPH0655739B2 (sv)
AT (1) AT391317B (sv)
AU (3) AU583489B2 (sv)
BE (1) BE901456A (sv)
CA (1) CA1245640A (sv)
CH (1) CH664568A5 (sv)
CY (1) CY1542A (sv)
DE (1) DE3500251C2 (sv)
DK (1) DK169891B1 (sv)
ES (1) ES8605514A1 (sv)
FI (1) FI82466C (sv)
FR (1) FR2560196B1 (sv)
GB (1) GB2152507B (sv)
GR (1) GR850065B (sv)
HK (1) HK48590A (sv)
HU (1) HU197569B (sv)
IE (1) IE58228B1 (sv)
IL (1) IL74043A (sv)
IT (1) IT1214648B (sv)
LU (1) LU85725A1 (sv)
NL (1) NL193541C (sv)
NZ (1) NZ210818A (sv)
PH (1) PH23286A (sv)
PT (1) PT79818B (sv)
SE (1) SE460420B (sv)
SG (1) SG32390G (sv)
ZA (1) ZA85276B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
EP0160842B1 (de) * 1984-04-09 1994-06-22 Schering Aktiengesellschaft 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
NL8700046A (nl) * 1986-01-24 1987-08-17 Sandoz Ag 8 alfa-acylaminoergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
US4981859A (en) * 1987-06-15 1991-01-01 Cycloalkylamides of (8 beta )-1-alkyl-6-(substituted)ergolines
US4931447A (en) * 1987-06-15 1990-06-05 Eli Lilly And Company Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto
DE3820159A1 (de) * 1987-06-23 1989-01-05 Sandoz Ag 8(alpha)-acylaminoergolin, seine herstellung und dieses enthaltende arzneimittel
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
GB8824744D0 (en) * 1988-10-21 1988-11-30 Erba Carlo Spa Antiemesis ergoline derivatives
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
CN107428745A (zh) 2015-01-20 2017-12-01 Xoc制药股份有限公司 麦角灵化合物及其用途
US9676776B2 (en) * 2015-01-20 2017-06-13 Xoc Pharmaceuticals, Inc. Isoergoline compounds and uses thereof
AU2018275873A1 (en) 2017-06-01 2019-12-19 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218323A (en) * 1965-11-16 Esters of i,g-dimethyl-b-ergolenyl carbamic acid
US2864822A (en) * 1956-10-22 1958-12-16 Lilly Co Eli 9-amino-7-methyl-belta10-ergolene and derivatives thereof
CH622519A5 (en) * 1974-07-05 1981-04-15 Hoechst Ag Process for the preparation of hydroxyalkylxanthines
US4348392A (en) * 1974-07-19 1982-09-07 Sandoz Ltd. 8α-Substituted ergoline-I derivatives
GB1517973A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
US3922347A (en) * 1974-12-19 1975-11-25 Lilly Co Eli Method of inhibiting prolactin secretion with 8-acylaminoergolenes
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
CH622518A5 (en) * 1976-12-14 1981-04-15 Sandoz Ag Process for the preparation of novel ergoline compounds
CH644606A5 (de) * 1980-09-23 1984-08-15 Sandoz Ag Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
NL8503426A (nl) * 1984-12-24 1986-07-16 Sandoz Ag 8alfa-acylamino-ergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto

Also Published As

Publication number Publication date
GB8500454D0 (en) 1985-02-13
DK12685D0 (da) 1985-01-10
IT1214648B (it) 1990-01-18
GB2152507B (en) 1987-07-15
US5077298A (en) 1991-12-31
CY1542A (en) 1991-03-22
PT79818A (en) 1985-02-01
AU2506688A (en) 1989-02-23
NZ210818A (en) 1989-02-24
ZA85276B (en) 1986-08-27
US4950672A (en) 1990-08-21
HUT37148A (en) 1985-11-28
NL8500008A (nl) 1985-08-01
DE3500251A1 (de) 1985-07-18
DE3500251C2 (de) 1995-01-26
BE901456A (fr) 1985-07-08
DK12685A (da) 1985-07-13
SE460420B (sv) 1989-10-09
AU583489B2 (en) 1989-05-04
DK169891B1 (da) 1995-03-27
IL74043A (en) 1988-10-31
ES539511A0 (es) 1986-03-16
IL74043A0 (en) 1985-04-30
FI850130L (fi) 1985-07-13
PH23286A (en) 1989-06-30
JPS60174783A (ja) 1985-09-09
AU2506788A (en) 1989-03-02
AU609539B2 (en) 1991-05-02
HK48590A (en) 1990-06-29
CA1245640A (en) 1988-11-29
FR2560196B1 (fr) 1986-07-18
AU618290B2 (en) 1991-12-19
FI82466B (fi) 1990-11-30
AT391317B (de) 1990-09-25
FI82466C (sv) 1991-03-11
ATA5985A (de) 1990-03-15
PT79818B (en) 1987-01-07
JPH0655739B2 (ja) 1994-07-27
AU3760985A (en) 1985-07-18
SG32390G (en) 1990-08-03
CH664568A5 (de) 1988-03-15
NL193541B (nl) 1999-09-01
FR2560196A1 (fr) 1985-08-30
GB2152507A (en) 1985-08-07
FI850130A0 (fi) 1985-01-11
IT8547538A0 (it) 1985-01-11
NL193541C (nl) 2000-01-04
IE850064L (en) 1985-07-12
SE8500107D0 (sv) 1985-01-10
SE8500107L (sv) 1985-07-13
HU197569B (en) 1989-04-28
ES8605514A1 (es) 1986-03-16
IE58228B1 (en) 1993-08-11
GR850065B (sv) 1985-05-03

Similar Documents

Publication Publication Date Title
EP0635003B1 (fr) Derives de perhydroisoindole comme antagonistes de la substance p
EP0711280B1 (fr) Derives de perhydroisoindole comme antagonistes de la substance p
EP0501892B1 (fr) Dérivés hétérocycliques diazotés N-substitués par un groupement biphénylméthyle, leur préparation, les compositions pharmaceutiques en contenant
EP0833822A1 (fr) Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
EP1115719A2 (fr) Derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2530625A1 (fr) Derives d'indole, procedes pour leur preparation et compositions pharmaceutiques les contenant
EP0934290B1 (fr) Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
LU85725A1 (fr) Nouvelles 8alpha-acylaminoergolines,leur preparation et leur utilisation comme medicaments
EP0611766A1 (fr) Dérivés de 2-amido-thiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament
CH652394A5 (fr) Derives indoliques, leur preparation et medicaments les renfermant.
IL101358A (en) Tiagabine hydrochloride crystalline monohydrate, its preparation and pharmaceutical preparations containing the same
FR2722190A1 (fr) Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
EP0532410A1 (fr) Dérivés hétérocycliques N-substitués, comme inhibiteurs de l'angiotensive II
CH667454A5 (fr) Derives d'indoles.
EP0620221A1 (fr) 5-Acylamino 1,2,4-thiadiazoles comme antagonistes ou agonistes de la cholécystokinine
EP0286515A1 (fr) Nouvelles amines tricycliques dérivées du tétrahydro-5,6,7,8 naphto [2,3b] dihydro-2,3 furanne, et du tétrahydro-6,7,8,9 5H-benzocyclohepta [2,3b] dihydro-2,3 furanne, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
EP1242389B1 (fr) Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2600061A1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
JPH0395161A (ja) (1,2,3,4―テトラヒドロ‐9‐アクリジンイミノ)シクロヘキサンカルボン酸および関連化合物
CH674008A5 (sv)
LU86226A1 (fr) Nouvelles 8-acylaminoergolines,leur preparation,leur utilisation comme medicaments et les compositions pharmaceutiques les contenant
FR2485530A1 (fr) Nouveaux derives du dibenz(cd,f)indole, leur preparation et leur application comme medicaments
CA2158663A1 (fr) Derives du perhydroisoindole, leur preparation et compositions pharmaceutiques en contenant
JPH09508917A (ja) フェニルピロール誘導体およびそのドーパミンd▲下3▼アンタゴニストとしての使用
EP0101379A1 (fr) Benzamides, leurs sels, procédé pour leur préparation et compositions pharmaceutiques les renfermant